# IBIO, INC. (IBIO) · Edgar & Edgarette company card

> Ibio, Inc. (IBIO) saw revenue fall 75.0% in FY2026 to $0 million, operating margin -35141% against a -3.8% median for pharmaceutical preparations, equity 86.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1420720 · fiscal year ended 2026-06-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/IBIO) · [JSON](https://www.pops4.com/boards/company/IBIO.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $100,000 |
| Revenue growth, 1 year | -75.0% |
| Revenue growth per year | -52.0% |
| Operating margin | -35141.0% (prior year -4650.5%) |
| Net margin | -33044.0% |
| Operating cash flow | −$23M |
| Capital spending | $578,000 |
| Free cash flow | −$24M |
| Cash | $56M |
| Long-term debt | — |
| Total assets | $99M |
| Total equity | $86M |
| Equity ÷ assets | 86.5% |
| Return on equity | -38.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -2.35 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative (-$23.2M in FY2026); operating loss: a margin of -35141.0% in FY2026; revenue is hard to predict: its 80% range is ±28%

## Edgarette's reading

Exposure: revenue $100K (FY2026). Experience: revenue down 75.0% on the year, down 52.0% a year over 4 years; operating margin -35141.0%, down from -4650.5%. Soundness: equity 86.5% of assets, return on equity -38.6%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $27K and $48K next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -35141.0% against a -3.8% median; growth -75.0% against 13.7%.

Range logged 2026-09-20, receipt 4aff03b73e67c5bb, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-10-19 ([filing](https://www.sec.gov/Archives/edgar/data/1420720/000142072026000032/0001420720-26-000032-index.htm))

## Recent filings

- 8-K · filed 2026-10-19 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1420720/000142072026000032/0001420720-26-000032-index.htm)
- 8-K · filed 2026-10-13 · 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1420720/000142072026000030/0001420720-26-000030-index.htm)
- 8-K · filed 2026-09-14 · 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1420720/000142072026000028/0001420720-26-000028-index.htm)
- DEF 14A · filed 2026-09-04 · [filing](https://www.sec.gov/Archives/edgar/data/1420720/000142072026000022/0001420720-26-000022-index.htm)
- 10-K · filed 2026-08-28 · [filing](https://www.sec.gov/Archives/edgar/data/1420720/000142072026000020/0001420720-26-000020-index.htm)
- 8-K · filed 2026-08-28 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1420720/000142072026000019/0001420720-26-000019-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001420720.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1420720

## Cite

POPS4, Edgar & Edgarette: IBIO, INC. (IBIO) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/IBIO. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.